Biomarker Solutions



Why biomarkers?

Biomarkers are particularly useful when translating pre-clinical to clinical findings (bench-to-bedsite). Biomarkers can be helpful:

  • when difficulties arise in the decision-making process with regard to investigational new drug (IND) applications, i.e, when trying to extrapolate results from preclinical animal studies to the use in humans.
  • for proof-of-principle and proof-of-concept studies. In the field of drug research, a company will often undertake research initially, to prove that the core ideas are workable (proof-of-principle) and feasible, before going further (first-in man studies, first-in-patients studies). The use of “biomarker-enhanced” proof-of-concept studies helps to establish viability, technical issues, and overall direction.
  • For stratification of patients.During phase-I, early phase-II and in the subsequent process during late phase-II and phase-III (or even phase-IV studies), biomarkers can be helpful, i.e., to stratify proband and patient groups („personalized medicine“).

© PI-PharmaImage Germany GmbH 2017 | Webdesign: blickpunkt x, Köln

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok Decline